Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease

NCT04448587 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Graft Vs Host Disease

Interventions

DRUG: Sitagliptin 100mg

Sponsor

Rabin Medical Center